|
⚲
|
| Keyboard |
| Khan Samina
✚
|
|
|---|---|
| CIK # | 0001903865 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001903865] | |
| 4 | [0001903865] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Khan Samina | |
| Reata Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-05-16 | Sell | 352 | $81.37 | 28,642 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-05-15 | Sell | 288 | $85.32 | 24,572 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-07 | Sell | 3,961 | $83.46 | 330,585 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-03 | Sell | 2,813 | $87.36 | 245,744 |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2023-03-02 | Option exercise | 25,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-02 | Sell | 18,956 | $85.02 | 1,611,639 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-02 | Option exercise | 25,000 | $27.32 | 683,000 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-02 | Sell | 2,649 | $85.38 | 226,172 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-03-02 | Sell | 3,395 | $83.70 | 284,162 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2023-01-03 | Grant | 11,756 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right-to-buy) · derivative
|
2023-01-03 | Grant | 47,738 | $0.00 |